Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 2
Submit an article Journal homepage
271
Views
9
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab

Rebecca L. ElstromDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]
,
Jia RuanDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
,
Paul J. ChristosDivision of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, NY, USA
,
Peter MartinDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
,
Daniel LebovicDivision of Hematology/Oncology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
,
Joseph OsborneDivision of Nuclear Medicine, Department of Radiology, Weill Cornell Medical College, New York, NY, USA
,
Stanley GoldsmithDivision of Nuclear Medicine, Department of Radiology, Weill Cornell Medical College, New York, NY, USA
,
June GreenbergDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
,
Richard R. FurmanDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
,
Anca AvramDivision of Nuclear Medicine, Department of Radiology, University of Michigan School of Medicine, Ann Arbor, MI, USA
,
Ryan PutmanDivision of Hematology/Oncology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
,
Erica ChapmanDivision of Hematology/Oncology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
,
Madhu MazumdarDivision of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, NY, USA
,
Kent GriffithDepartment of Biostatistics, University of Michigan School of Medicine, Ann Arbor, MI, USA
,
Morton ColemanDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
,
John P. LeonardDivision of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
&
Mark S. KaminskiDivision of Hematology/Oncology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
 show all
Pages 342-346 | Received 05 Feb 2014, Accepted 13 Feb 2014, Published online: 17 Jun 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mahsa Eskian, MirHojjat Khorasanizadeh, Pier Luigi Zinzani, Tim M. Illidge & Nima Rezaei. (2019) Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma. International Reviews of Immunology 38:2, pages 79-91.
Read now
Mickaël Bourgeois, Clément Bailly, Mathieu Frindel, François Guerard, Michel Chérel, Alain Faivre-Chauvet, Françoise Kraeber-Bodéré & Caroline Bodet-Milin. (2017) Radioimmunoconjugates for treating cancer: recent advances and current opportunities. Expert Opinion on Biological Therapy 17:7, pages 813-819.
Read now

Articles from other publishers (7)

Jia Wen Yeap & Mei Lan Tan. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 54 .
Tomoko Tachibana, Yukie Yoshii, Hiroki Matsumoto, Ming-Rong Zhang, Kotaro Nagatsu, Fukiko Hihara, Chika Igarashi, Aya Sugyo, AtsushiB Tsuji & Tatsuya Higashi. (2022) Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with 64 Cu-labeled cetuximab against peritoneal dissemination of gastric cancer in a mouse model . Journal of Cancer Research and Therapeutics 18:4, pages 907.
Crossref
Aurélie Rondon, Jacques Rouanet & Françoise Degoul. (2021) Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials. Cancers 13:21, pages 5570.
Crossref
Zhuoran Zhang, Xingli Zhao, Dongfang Wang, Dayson Moreira, Yu-Lin Su, Marice Alcantara, Piotr Swiderski, Jeffrey Wong, Susanta Hui, Stephen Forman, Larry Kwak & Marcin Kortylewski. (2021) Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy. Molecular Therapy 29:3, pages 1214-1225.
Crossref
Koichiro Abe. 2018. Resistance to Ibritumomab in Lymphoma. Resistance to Ibritumomab in Lymphoma 33 57 .
Davinia Ryan & Lisa Bodei. (2017) Radioimmunotherapy in Oncology. Current Radiology Reports 5:12.
Crossref
Damian J. Green & Oliver W. Press. (2017) Whither Radioimmunotherapy: To Be or Not To Be?. Cancer Research 77:9, pages 2191-2196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.